Geneos Therapeutics
Geneos Therapeutics, based in Plymouth Meeting, PA, is a Phase 2 biotherapeutics company dedicated to the development of personalized therapeutic cancer vaccines (PTCVs) utilizing its proprietary GT-EPIC platform. These vaccines are designed to target up to 40 unique tumor neoantigens, thereby harnessing the patient's immune system to combat various types of cancer.
The PTCVs are administered intradermally and are complemented by a cytokine adjuvant and electroporation, aimed at inducing a robust immune response. With a focus on hepatocellular carcinoma, Geneos Therapeutics is advancing toward potential registrational clinical trials and continues to demonstrate promising results in the fight against cancer.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

